That disconnect is what enthusiast X Finance Bull leaned on in a recent post on X. Recent developments from Ripple itself suggest that the claim is not as easy to dismiss as it once was. Perhaps it’s time to stop staring at the price and start reading the fine print of a company that’s clearly been playing chess while the rest of us were still learning checkers.
The price, oh the price, hovers tantalizingly close to the $0.25 mark, a figure that seems to hold as much significance as a hat at a society wedding. Yet, resistance, that implacable foe, looms large, threatening to send our protagonist into a tailspin of despair. Ali Chartz, a name that rolls off the tongue like a particularly dry sherry, opines that ADA stands at a “make-or-break” point, a phrase so overused it has lost all meaning, yet here it is, trotted out once more for our edification.
Anthropic Trust, that austere guardian that watches over the company without flagging its own coffers, has chosen its newest champion: Vas Narasimhan, skipper of Novartis, a man who has danced with the leviathans of the drug industry and coaxed dozens of medications into the arms of the people. His appointment, unveiled on the fourteenth of April, will shift the board’s balance, allowing the Trust’s hand to write the next chapter of Anthropic’s destiny.
In an epistolary outpouring, the FCA beckons all crypto firms and stakeholders to lend their ears-and opinions-to this grand finale of consultations. They aim to illuminate the “regulatory perimeter” for crypto assets, a term so grand it could make even the most seasoned bureaucrat shed a tear of joy.
As Bitcoin briefly surged past $76,000 on April 15th, I started seeing renewed excitement about a bull market. However, my research at Glassnode, using our ‘true market mean’ (TMM) metric – which essentially calculates the average cost basis of *active* Bitcoin holders by excluding lost or inactive coins – tells a different story. As of mid-April, our data showed Bitcoin had been trading below the average entry price for active investors for 75 days straight. This suggests the rally might not be as straightforward as some believe.
A volume surge of such magnitude accompanied this advance that one could almost hear the collective gasp of the market. The price, previously loitering in the $2.00 range like a forgotten guest at a party, shot up to above $6.60 with the alacrity of a Bertie Wooster evading an unwanted fiancée. ORDI now finds itself testing the 0.382 Fibonacci retracement at $6.488, having opened the session at a modest $3.444. Quite the leap, what?
However, lest we get too carried away, Bloomberg’s own Eric Balchunas has burst our euphoric bubble, predicting that this new offering will prove to be a Herculean task to sell. He anticipates that Schwab’s foray into the crypto realm will struggle to hold its own against the existing ETF offerings, which have, let’s face it, been the darling of the investment world-at least until the next shiny object appears.
Key Takeaways (for those who still believe in “key” things):
